Gene · 10097
Papers2,756
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,756
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Next-Generation Sequencing in the Assessment of the Transcriptomic Landscape of DNA Damage Repair Genes in Abdominal Aortic Aneurysm, Chronic Venous Disease and Lower Extremity Artery Disease. | Int J Mol Sci | 2022 | 36614026 | PubTator, text mining | PubMed |
| CRISPR/Cas-Based Approaches to Study Schizophrenia and Other Neurodevelopmental Disorders. | Int J Mol Sci | 2022 | 36613684 | PubTator, text mining | PubMed |
| Upregulation of Actin-Related Protein 2 (ACTR2) Exacerbated the Malignancy of Diffuse Large B-Cell Lymphoma through Activating Wnt Signaling. | Comput Math Methods Med | 2022 | 36570337 | PubTator, text mining | PubMed |
| The molecular basis of the dichotomous functionality of MAP4K4 in proliferation and cell motility control in cancer. | Front Oncol | 2022 | 36568222 | PubTator, text mining | PubMed |
| Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases. | Viruses | 2022 | 36560690 | PubTator, text mining | PubMed |
| S-Benproperine, an Active Stereoisomer of Benproperine, Suppresses Cancer Migration and Tumor Metastasis by Targeting ARPC2. | Pharmaceuticals (Basel) | 2022 | 36558913 | PubTator, text mining | PubMed |
| Chondrocyte De-Differentiation: Biophysical Cues to Nuclear Alterations. | Cells | 2022 | 36552775 | PubTator, text mining | PubMed |
| Frontier and hotspot evolution in Wiskott-Aldrich syndrome: A bibliometric analysis from 2001 to 2021. | Medicine (Baltimore) | 2022 | 36550896 | PubTator, text mining | PubMed |
| Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells. | Clin Epigenetics | 2022 | 36517875 | PubTator, text mining | PubMed |
| Arf GTPase activates the WAVE regulatory complex through a distinct binding site. | Sci Adv | 2022 | 36516255 | PubTator, text mining | PubMed |
| Identification of a pharmacological approach to reduce ACE2 expression and development of an in vitro COVID-19 viral entry model. | J Virus Erad | 2022 | 36514715 | PubTator, text mining | PubMed |
| OMICS Approaches Evaluating Keloid and Hypertrophic Scars. | Int J Inflam | 2022 | 36483731 | PubTator, text mining | PubMed |
| Proteomic characteristics of saliva in patients with different subgroups of IgG4-RD. | Front Immunol | 2022 | 36483554 | PubTator, text mining | PubMed |
| A network of mixed actin polarity in the leading edge of spreading cells. | Commun Biol | 2022 | 36473943 | PubTator, text mining | PubMed |
| Nanotopographical cues for regulation of macrophages and osteoclasts: emerging opportunities for osseointegration. | J Nanobiotechnology | 2022 | 36463225 | PubTator, text mining | PubMed |
| Proteomic signatures of schizophrenia-sourced iPSC-derived neural cells and brain organoids are similar to patients' postmortem brains. | Cell Biosci | 2022 | 36451159 | PubTator, text mining | PubMed |
| Mechanism of actin filament branch formation by Arp2/3 complex revealed by a high-resolution cryo-EM structureof the branch junction. | Proc Natl Acad Sci U S A | 2022 | 36442092 | PubTator, text mining | PubMed |
| Identification and validation of a signature based on macrophage cell marker genes to predict recurrent miscarriage by integrated analysis of single-cell and bulk RNA-sequencing. | Front Immunol | 2022 | 36439123 | PubTator, text mining | PubMed |
| Inhibition of Arp2/3 Complex after ADP-Ribosylation of Arp2 by Binary Clostridioides Toxins. | Cells | 2022 | 36429089 | PubTator, text mining | PubMed |
| JMJD1C Regulates Megakaryopoiesis in In Vitro Models through the Actin Network. | Cells | 2022 | 36429088 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10097/papers?page=13